메뉴 건너뛰기




Volumn 256, Issue 1, 2012, Pages 72-78

Metabolic surgery for non-obese type 2 diabetes: Incretins, adipocytokines, and insulin secretion/resistance changes in a 1-year interventional clinical controlled study

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; DIPEPTIDYL PEPTIDASE IV; GASTRIC INHIBITORY POLYPEPTIDE; GLIBENCLAMIDE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN; INSULIN; LEPTIN; METFORMIN; ORAL ANTIDIABETIC AGENT; PROTON PUMP INHIBITOR;

EID: 84863304937     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3182592c62     Document Type: Article
Times cited : (47)

References (33)
  • 1
    • 34247637288 scopus 로고    scopus 로고
    • International diabetes federation: A consensus on type 2 diabetes prevention
    • Alberti KG, Zimmet P, Shaw J. International Diabetes Federation: a consensus on type 2 diabetes prevention. Diabet Med. 2007;24:451-463.
    • (2007) Diabet Med , vol.24 , pp. 451-463
    • Alberti, K.G.1    Zimmet, P.2    Shaw, J.3
  • 2
    • 0032456709 scopus 로고    scopus 로고
    • Insulin resistance versus insulin deficiency in non-insulin dependent diabetes mellitus: Problems and prospects
    • Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin dependent diabetes mellitus: problems and prospects. Endocr Rev. 1998;19:477-490.
    • (1998) Endocr Rev , vol.19 , pp. 477-490
    • Ferrannini, E.1
  • 3
    • 9444253486 scopus 로고    scopus 로고
    • Beta-cell function in obesity: Effects of weight loss
    • Ferrannini E, Camastra S, Gastaldelli A, et al. Beta-cell function in obesity: effects of weight loss. Diabetes. 2004;53(suppl 3):S26-S33.
    • (2004) Diabetes , vol.53 , Issue.SUPPL. 3
    • Ferrannini, E.1    Camastra, S.2    Gastaldelli, A.3
  • 4
    • 41149115561 scopus 로고    scopus 로고
    • Islet inflammation in type 2 diabetes: From metabolic stress to therapy
    • Donath MY, Schumann DM, Faulenbach M, et al. Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care. 2008;31(suppl 2):S161-S164.
    • (2008) Diabetes Care , vol.31 , Issue.SUPPL. 2
    • Donath, M.Y.1    Schumann, D.M.2    Faulenbach, M.3
  • 5
    • 4043101702 scopus 로고    scopus 로고
    • Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis
    • Gastaldelli A, Miyazaki Y, Pettiti M, et al. Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis. J Clin Endocrinol Metab. 2004;89:3914-3921.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 3914-3921
    • Gastaldelli, A.1    Miyazaki, Y.2    Pettiti, M.3
  • 6
    • 77954250537 scopus 로고    scopus 로고
    • The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action
    • Hare KJ, Vilsbøll T, Asmar M, et al. The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action. Diabetes. 2010;59:1765-1770.
    • (2010) Diabetes. , vol.59 , pp. 1765-1770
    • Hare Kj, V.1
  • 7
    • 34547586659 scopus 로고    scopus 로고
    • Reduced incretin effect in type 2 diabetes. Cause or consequence of the diabetic state?
    • Knop F,Vilsboll T,Hojberg PV, et al. Reduced incretin effect in type 2 diabetes. Cause or consequence of the diabetic state? Diabetes. 2007;56:1951-1959.
    • (2007) Diabetes , vol.56 , pp. 1951-1959
    • Knop, F.1    Vilsboll, T.2    Hojberg, P.V.3
  • 8
    • 2942689978 scopus 로고    scopus 로고
    • Gastric bypass for obesity: Mechanisms of weight loss and diabetes resolution
    • Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab. 2004;89:2608-2615.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 2608-2615
    • Cummings, D.E.1    Overduin, J.2    Foster-Schubert, K.E.3
  • 9
    • 5044242948 scopus 로고    scopus 로고
    • Bariatric surgery: A systematic review and meta-analysis
    • Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-1737.
    • (2004) JAMA , vol.292 , pp. 1724-1737
    • Buchwald, H.1    Avidor, Y.2    Braunwald, E.3
  • 10
    • 33747038162 scopus 로고    scopus 로고
    • Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery
    • Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes. 2006;55:2025-2031.
    • (2006) Diabetes , vol.55 , pp. 2025-2031
    • Guidone, C.1    Manco, M.2    Valera-Mora, E.3
  • 11
    • 65449152884 scopus 로고    scopus 로고
    • Glp-1 and adiponectin: Effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism
    • de Carvalho CP, Marin DM, de Souza AL, et al. GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism. Obes Surg. 2009;19:313-320.
    • (2009) Obes Surg , vol.19 , pp. 313-320
    • De Carvalho, C.P.1    Marin, D.M.2    De Souza, A.L.3
  • 12
    • 47549094687 scopus 로고    scopus 로고
    • Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes
    • Laferr̀ere B, Teixeira J,McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008;93:2479-2485.
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 2479-2485
    • Laferr̀ere B, T.1
  • 13
    • 0842283988 scopus 로고    scopus 로고
    • Effect of duodenal-jejunal exclusion in a nonobese animal model of type 2 diabetes: A new perspective for an old disease
    • Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a nonobese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239:1-11.
    • (2004) Ann Surg , vol.239 , pp. 1-11
    • Rubino, F.1    Marescaux, J.2
  • 14
    • 34347338781 scopus 로고    scopus 로고
    • The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in goto-kakizaki rats
    • Pacheco D, de Luis DA, Romero A, et al. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats. Am J Surg. 2007;194:221-224.
    • (2007) Am J Surg , vol.194 , pp. 221-224
    • Pacheco, D.1    De Luis, D.A.2    Romero, A.3
  • 15
    • 33947427175 scopus 로고    scopus 로고
    • Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: A report of 2 cases
    • Cohen RV, Schiavon CA, Pinheiro JS, et al. Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases. Surg Obes Relat Dis. 2007;3:195-197.
    • (2007) Surg Obes Relat Dis , vol.3 , pp. 195-197
    • Cohen, R.V.1    Schiavon, C.A.2    Pinheiro, J.S.3
  • 16
    • 65449123498 scopus 로고    scopus 로고
    • Laparoscopic duodenaljejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI<30 kg/m2 (LBMI)
    • Ramos AC, Galṽao Neto MP, de Souza YM, et al. Laparoscopic duodenaljejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI<30 kg/m2 (LBMI). Obes Surg. 2009;19:307-311.
    • (2009) Obes Surg , vol.19 , pp. 307-311
    • Ramos Ac, G.1
  • 17
    • 67651001967 scopus 로고    scopus 로고
    • Surgery for nonobese type 2 diabetic patients: An interventional study with duodenal-jejunal exclusion
    • Geloneze B, Geloneze SR, Fiori C, et al. Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion. Obes Surg. 2009;19:1077-1083.
    • (2009) Obes Surg , vol.19 , pp. 1077-1083
    • Geloneze, B.1    Geloneze, S.R.2    Fiori, C.3
  • 18
    • 33646737399 scopus 로고    scopus 로고
    • Brazilian diabetes society consensus statement-intensive insulin therapy and insulin pump therapy
    • Malerbi D, Damiani D, Rassi N, et al. Brazilian Diabetes Society consensus statement-intensive insulin therapy and insulin pump therapy. Arq Bras Endocrinol Metabol. 2006;50:125-135.
    • (2006) Arq Bras Endocrinol Metabol , vol.50 , pp. 125-135
    • Malerbi, D.1    Damiani, D.2    Rassi, N.3
  • 19
    • 33746588255 scopus 로고    scopus 로고
    • Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the american diabetes association and the european association for the study of diabetes
    • Nathan DM, Buse JB, Davisdon MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006;29:1963-1972.
    • (2006) Diabetes Care , vol.29 , pp. 1963-1972
    • Nathan, D.M.1    Buse, J.B.2    Davisdon, M.B.3
  • 20
    • 0032821965 scopus 로고    scopus 로고
    • Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp
    • Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462-1470.
    • (1999) Diabetes Care , vol.22 , pp. 1462-1470
    • Matsuda, M.1    Defronzo, R.A.2
  • 21
    • 0034049630 scopus 로고    scopus 로고
    • Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity
    • Stumvoll M, Mitrakou A, PimentaW, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care. 2000;23:295-301.
    • (2000) Diabetes Care , vol.23 , pp. 295-301
    • Stumvoll, M.1    Mitrakou, A.2    Pimenta, W.3
  • 22
    • 0021813187 scopus 로고
    • Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
    • Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
    • (1985) Diabetologia , vol.28 , pp. 412-419
    • Matthews, D.R.1    Hosker, J.P.2    Rudenski, A.S.3
  • 23
    • 0031732845 scopus 로고    scopus 로고
    • Pancreatic β-cell responsiveness during meal tolerance test: Model assessment in normal subjects and subjects with newly diagnosed noninsulin-dependent diabetes mellitus
    • Hovorka R, Chassin L, Luzio SD, et al. Pancreatic β-cell responsiveness during meal tolerance test: model assessment in normal subjects and subjects with newly diagnosed noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1998;83:744-750.
    • (1998) J Clin Endocrinol Metab , vol.83 , pp. 744-750
    • Hovorka, R.1    Chassin, L.2    Luzio, S.D.3
  • 24
    • 70549111807 scopus 로고    scopus 로고
    • Evaluation of proposed oral disposition index measures in relation to the actual disposition index
    • Retnakaran R, Qi Y, Goran MI, et al. Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med. 2009;26:1198-1203.
    • (2009) Diabet Med , vol.26 , pp. 1198-1203
    • Retnakaran, R.1    Qi, Y.2    Goran, M.I.3
  • 25
    • 33750331204 scopus 로고    scopus 로고
    • The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes
    • Rubino F, Forgione A, Cummings D, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741-749.
    • (2006) Ann Surg , vol.244 , pp. 741-749
    • Rubino, F.1    Forgione, A.2    Cummings, D.3
  • 26
    • 48749131707 scopus 로고    scopus 로고
    • Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test
    • Shen S, Hanley AJ, Vuksan V, et al. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity. 2008;16:1901-1907.
    • (2008) Obesity , vol.16 , pp. 1901-1907
    • Shen, S.1    Hanley, A.J.2    Vuksan, V.3
  • 27
    • 34948825485 scopus 로고    scopus 로고
    • Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice
    • Morioka T, Asilmaz E, Hu J, et al. Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. J Clin Invest. 2007;117:2860-2868.
    • (2007) J Clin Invest , vol.117 , pp. 2860-2868
    • Morioka, T.1    Asilmaz, E.2    Hu, J.3
  • 28
    • 12744273119 scopus 로고    scopus 로고
    • Luminal leptin induces rapid inhibition of active intestinal absorption of glucose mediated by sodium-glucose cotransporter 1
    • Ducroc R, Guilmeau S, Akasbi K, et al. Luminal leptin induces rapid inhibition of active intestinal absorption of glucose mediated by sodium-glucose cotransporter 1. Diabetes. 2005;54:348-354.
    • (2005) Diabetes , vol.54 , pp. 348-354
    • Ducroc, R.1    Guilmeau, S.2    Akasbi, K.3
  • 29
    • 0035659558 scopus 로고    scopus 로고
    • Serum leptin levels after bariatric surgery across a range of glucose tolerance from normal to diabetes
    • Geloneze B, TambasciaMA, Pareja JC, et al. Serum leptin levels after bariatric surgery across a range of glucose tolerance from normal to diabetes. Obes Surg. 2001;11:693-698.
    • (2001) Obes Surg , vol.11 , pp. 693-698
    • Geloneze, B.1    Tambascia, M.A.2    Pareja, J.C.3
  • 30
    • 34447301013 scopus 로고    scopus 로고
    • Luminal leptin inhibits intestinal sugar absorption in vivo
    • Inigo C, Patel N, Kellett GL, et al. Luminal leptin inhibits intestinal sugar absorption in vivo. Acta Physiol. 2007;190:303-310.
    • (2007) Acta Physiol , vol.190 , pp. 303-310
    • Inigo, C.1    Patel, N.2    Kellett, G.L.3
  • 31
    • 13344293675 scopus 로고    scopus 로고
    • Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells
    • Moens K, Heimberg H, Flamez D, et al. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes. 1996;45:257-261.
    • (1996) Diabetes , vol.45 , pp. 257-261
    • Moens, K.1    Heimberg, H.2    Flamez, D.3
  • 32
    • 55249122067 scopus 로고    scopus 로고
    • Glucose-dependent insulinotropic polypeptide (GIP) stimulates transepithelial glucose transport
    • Singh SK, Bartoo AC, Krishnan S, et al. Glucose-dependent insulinotropic polypeptide (GIP) stimulates transepithelial glucose transport. Obesity. 2008;16:2412-2416.
    • (2008) Obesity , vol.16 , pp. 2412-2416
    • Singh, S.K.1    Bartoo, A.C.2    Krishnan, S.3
  • 33
    • 72249113386 scopus 로고    scopus 로고
    • Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice
    • Moriya R, Shirakura T, Ito J, et al. Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice. Am J Physiol Endocrinol Metab. 2009;297:E1358-E1365.
    • (2009) Am J Physiol Endocrinol Metab , vol.297
    • Moriya, R.1    Shirakura, T.2    Ito, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.